180 related articles for article (PubMed ID: 6268553)
1. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
[TBL] [Abstract][Full Text] [Related]
2. Increased incidence of IgA antibodies to the Epstein-Barr virus-associated viral capsid antigen and early antigens in patients with chronic lymphocytic leukemia.
Dölken G; Bross KJ; Hecht T; Brugger W; Löhr GW; Hirsch FW
Int J Cancer; 1986 Jul; 38(1):55-9. PubMed ID: 3013785
[TBL] [Abstract][Full Text] [Related]
3. Significance of specific Epstein-Barr virus IgA and elevated IgG antibodies to viral capsid antigens in nasopharyngeal carcinoma patients.
Hadar T; Rahima M; Kahan E; Sidi J; Rakowsky E; Sarov B; Sarov I
J Med Virol; 1986 Dec; 20(4):329-39. PubMed ID: 3025351
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to Epstein-Barr virus in nasopharyngeal carcinoma, tonsillar carcinoma and control groups.
Oberender H; Nowak R; Donner A; Kunkel M; Gärtner L; Scholtz HJ
Acta Virol; 1983 May; 27(3):277-81. PubMed ID: 6138990
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus-specific antibodies in Epstein-Barr virus-positive and -negative gastric carcinoma cases in Japan.
Shinkura R; Yamamoto N; Koriyama C; Shinmura Y; Eizuru Y; Tokunaga M
J Med Virol; 2000 Apr; 60(4):411-6. PubMed ID: 10686024
[TBL] [Abstract][Full Text] [Related]
6. Subclass reactivity to Epstein-Barr virus capsid antigen in primary and reactivated EBV infections.
Linde A; Andersson J; Lundgren G; Wahren B
J Med Virol; 1987 Feb; 21(2):109-21. PubMed ID: 3029317
[TBL] [Abstract][Full Text] [Related]
7. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma.
Tiwawech D; Srivatanakul P; Karaluk A; Ishida T
Asian Pac J Cancer Prev; 2003; 4(2):113-8. PubMed ID: 12875623
[TBL] [Abstract][Full Text] [Related]
8. [Demonstration of IgG- and IgA-antibodies against Epstein-Barr virus-associated antigens with a microtiter enzyme immunoassay system. The determination of serum antibodies against the viral capsid antigen and the early antigen complex in the sera of tumor and infectious mononucleosis patients].
Dölken G; Bitzer M; Bross KJ; Brugger W; Boldt C; Hirsch FW; Weitzmann U; Löhr GW
Dtsch Med Wochenschr; 1984 Nov; 109(48):1837-43. PubMed ID: 6094138
[TBL] [Abstract][Full Text] [Related]
9. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
10. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
[TBL] [Abstract][Full Text] [Related]
11. Epstein-barr virus VCA IgM and EBNA IgG antibodies titered by immunofluorescence in microplates. A semi-automated method based on microtiter system.
Lamy ME; Favart AM; Leclercq MF; Segas M; Mendez M; Lhoir C; Cornu C; Burtonboy G
Med Microbiol Immunol; 1982; 170(4):247-53. PubMed ID: 6285158
[TBL] [Abstract][Full Text] [Related]
12. IgG and IgA antibodies to Epstein-Barr virus in nasopharyngeal carcinoma patients.
Gong SH; Lynn TC; Yang CS
Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):8-15. PubMed ID: 211015
[TBL] [Abstract][Full Text] [Related]
13. Decreased antibody reactivity to Epstein-Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus.
Hyöty H; Räsänen L; Hiltunen M; Lehtinen M; Huupponen T; Leinikki P
APMIS; 1991 Apr; 99(4):359-63. PubMed ID: 1645169
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus antibody patterns preceding the diagnosis of nasopharyngeal carcinoma.
Chan CK; Mueller N; Evans A; Harris NL; Comstock GW; Jellum E; Magnus K; Orentreich N; Polk BF; Vogelman J
Cancer Causes Control; 1991 Mar; 2(2):125-31. PubMed ID: 1651778
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
Nystad TW; Myrmel H
J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus serology in bone marrow transplantations: a one-year retrospective study with detection of EBV IgM-VCA-specific antibodies.
Morinet F; Icart J; Ruelle C; Gluckman E; Perol Y
J Med Virol; 1986 Apr; 18(4):349-60. PubMed ID: 3011981
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-associated antibody pattern in untreated non-Hodgkin lymphoma patients. Relationship to clinical variables and lymphocyte functions.
Lindemalm C; Biberfeld P; Björkholm M; Henle G; Henle W; Holm G; Johansson B; Klein G; Mellstedt H
Int J Cancer; 1983 Dec; 32(6):675-82. PubMed ID: 6317577
[TBL] [Abstract][Full Text] [Related]
18. Elevated IgA antibodies to Epstein-Barr virus in children with chronic active Epstein-Barr virus infection.
Wakiguchi H; Fujieda M; Kubota H; Matsumoto K; Wakiguchi A; Kurashige T; Oda M
Acta Med Okayama; 1989 Jun; 43(3):193-6. PubMed ID: 2548373
[TBL] [Abstract][Full Text] [Related]
19. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
Touge C; Agawa H; Sairenji T; Inoue Y
Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
[TBL] [Abstract][Full Text] [Related]
20. Endogenous reactivation of Epstein-Barr virus infections.
Sumaya CV
J Infect Dis; 1977 Mar; 135(3):374-9. PubMed ID: 191540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
